| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/11/2011 | CN101129209B Traditional Chinese medicine beverage for replenishing essence and delaying aging |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939654 Platelet derived growth factor (PDGF) nucleic acid ligand complexes |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939549 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof |
| 05/10/2011 | US7939467 Controlling broadleaf plants and weeds and grasses |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2451279C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/05/2011 | WO2011053860A2 Mesenchymal stromal cell populations and methods of using same |
| 05/05/2011 | WO2011052765A1 Alleviator for renal disorders caused by administration of platinum-containing drug |
| 05/05/2011 | WO2010047765A8 Nanostructures for drug delivery |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105584 Rtp80il sirna compounds and methods of use thereof |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105565 Water soluble small molecule inhibitors of the cystic fibrosis transmembrane conductance regulator |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105520 Pyrimidine compounds as delta opioid receptor modulators |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105434 2-amino purine derivatives and their use as anti-herpetic agents |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105399 Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using mfg-e8 |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104270 Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| 05/05/2011 | US20110104269 Compositions for the oral delivery of corticosteroids |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/04/2011 | EP2316976A1 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316488A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 05/04/2011 | EP2316477A1 Immunogenic LHRH compositions and methods relating thereto |
| 05/04/2011 | EP2316451A1 Use of melatonin in preventing postoperative complications |
| 05/04/2011 | EP2316450A1 Amino-methyl substituted tetracycline compounds |
| 05/04/2011 | EP1414439B1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/04/2011 | CN201814844U Fumigating belt for a plurality of pulse |
| 05/04/2011 | CN1981813B Guizhi Fuling solution solid dispersate |
| 05/04/2011 | CN1847229B 2,4,8- trisubstituted-8H- pyridine[2,3-d] pyridine -7-one compound |
| 05/04/2011 | CN102046165A Methods of treating fibrotic disorders |
| 05/04/2011 | CN102046163A Use of a combination of udenafil and alfuzosin or oxybutynin for the treatment of overactive bladder. |
| 05/04/2011 | CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof |
| 05/04/2011 | CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof |
| 05/04/2011 | CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester |
| 05/04/2011 | CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl |
| 05/04/2011 | CN102038939A Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection |
| 05/04/2011 | CN102038909A Medicament for treating renal failure |
| 05/04/2011 | CN102038882A Traditional Chinese medicine prescription for treating children acute nephritis |
| 05/04/2011 | CN102038879A Longhairy antenoron herb calculus-removing pill |
| 05/04/2011 | CN102038836A New application of compound kuh-seng injection in preparation of medicaments for treating prostatitis diseases |
| 05/04/2011 | CN102038823A Effective medicine for treating retention of urine |
| 05/04/2011 | CN102038786A Preparation method of morinda officinalis traditional Chinese medicine |
| 05/04/2011 | CN102038741A Traditional Chinese medicine for treating prostate diseases and making method thereof |
| 05/04/2011 | CN102038721A Pinus extract and application thereof |
| 05/04/2011 | CN102038719A Preparation for Hirsutella sinensis fermented powder extract and application of Hirsutella sinensis fermented powder extract in preventing and treating renal failure |
| 05/04/2011 | CN102038671A Medicinal composition containing levocarnitine and hydroxybenzene sulfonate |
| 05/04/2011 | CN102038658A Epristeride tablets with high dissolution rate and preparation method thereof |
| 05/04/2011 | CN102038647A Preparation method for coenzyme A freeze-dried powder injection |
| 05/04/2011 | CN102038638A Clindamycin hydrochloride injection and preparation method thereof |
| 05/04/2011 | CN101647931B Traditional Chinese medicine for promoting urination and dissolving and discharging calculus |
| 05/04/2011 | CN101628050B Traditional Chinese medicine preparation for treating prostate gland diseases and preparation method thereof |
| 05/04/2011 | CN101612275B Traditional Chinese medicine for treating nephrotic syndrome and preparation method thereof |
| 05/04/2011 | CN101530487B Application of rubus parvifolius saponin series compound in preparing medicines for treating prostatitis disease |
| 05/04/2011 | CN101491533B Use of baicalin in preparing medicine |
| 05/04/2011 | CN101032483B Hydantoin derivative for adjusting estrogen receptor activity and application thereof |
| 05/04/2011 | CN101019627B Micro jet and instantaneous high pressure process of preparing whole lily powder |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | CA2489824C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 04/28/2011 | WO2011049475A1 The new application of 2-pyrrolidone derivatives |
| 04/28/2011 | WO2011049327A2 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof |
| 04/28/2011 | WO2011049042A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient |
| 04/28/2011 | WO2011048136A1 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders |
| 04/28/2011 | WO2011047770A2 Pyrazolopyrimidine derivatives |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011008543A3 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| 04/28/2011 | WO2010089128A3 Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098337 Inhibitors of RTP801 and their use in disease treatment |
| 04/28/2011 | US20110098336 Pyrrolidin-2-one derivatives as androgen receptor modulator |
| 04/28/2011 | US20110098328 Heterocyclic derivatives as modulators of ion channels |
| 04/28/2011 | US20110098304 Small molecule inhibitors of PARP activity |
| 04/28/2011 | US20110097395 Oral Pharmaceutical Compositions of Buprenorphine and Method of Use |
| 04/28/2011 | US20110097379 Directed stem cell recruitment |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
| 04/28/2011 | US20110097341 Treatment of Chronic Prostatitis |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |